{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:45Z","timestamp":1790776845216,"version":"4.1.0"},"reference-count":49,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>The Joint Heads of Medicines Agencies and European Medicines Agency's (HMA\/EMA) big data initiative paves the way for better integration of real\u2010world data, including data from patient registries, into regulatory decisions on medicines. This article focuses on the outcome of a two\u2010day multistakeholder workshop organized by EMA in 2024, which explored ways to optimize the EMA qualification procedure for patient registries, and to establish the value and enable the use of these data across the full spectrum of research questions. Key recommendations include the need to clarify the aim, scope, and added value of the qualification of registries, coupled with a review of the procedural steps to ensure the process is fit\u2010for\u2010purpose to evaluate the use of registries in specific regulatory contexts. Further recommendations focused on strengthening interactions between stakeholders, as well as providing them with enhanced support by increasing awareness of publicly available tools that could leverage the potential of registry data, together with existing guidance. The European Medicines Regulatory Network is now working together with all relevant stakeholders, including the EMA scientific committees and working parties, the Joint HMA\/EMA Network Data Steering Group and existing focus groups with external partners, to implement concrete actions that will address these recommendations. Among others, the update of existing guidance, the development of templates and Questions &amp; Answers documents, and the design of appropriate communication and stakeholder engagement plans will aid in achieving the common goal of making optimal use of patient registry data to support public health in the European Union.<\/jats:p>","DOI":"10.1002\/cpt.3733","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:04:37Z","timestamp":1748916277000},"page":"551-560","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Optimizing Patient Registries for Regulatory Decision Making \u2010 Key Learnings From an <scp>HMA<\/scp>\/<scp>EMA<\/scp> Multistakeholder Workshop"],"prefix":"10.1002","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1824-4148","authenticated-orcid":false,"given":"Kelly","family":"Plueschke","sequence":"first","affiliation":[{"name":"European Medicines Agency  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9093-2893","authenticated-orcid":false,"given":"Carla","family":"Jonker","sequence":"additional","affiliation":[{"name":"European Medicines Agency  Amsterdam The Netherlands"},{"name":"Medicines Evaluation Board (MEB)  Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8203-7188","authenticated-orcid":false,"given":"Hanna","family":"Kankanen","sequence":"additional","affiliation":[{"name":"European Medicines Agency  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Vetter","sequence":"additional","affiliation":[{"name":"European Medicines Agency  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-0955","authenticated-orcid":false,"given":"Bruno","family":"Sepodes","sequence":"additional","affiliation":[{"name":"Faculdade de Farm\u00e1cia Universidade de Lisboa  Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-6997","authenticated-orcid":false,"given":"Lutz","family":"Naehrlich","sequence":"additional","affiliation":[{"name":"European Cystic Fibrosis Society Patient Registry  Karup Denmark"},{"name":"Department of Pediatrics University of Giessen  Giessen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hillert","sequence":"additional","affiliation":[{"name":"Big Multiple Sclerosis Data Network Karolinska Institute  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracy","family":"Crane","sequence":"additional","affiliation":[{"name":"Global Regulatory Science Roche Pharmaceuticals  Welwyn Garden City UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Straus","sequence":"additional","affiliation":[{"name":"Medicines Evaluation Board (MEB)  Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Foggi","sequence":"additional","affiliation":[{"name":"Italian Medicines Agency (AIFA)  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Martin","sequence":"additional","affiliation":[{"name":"Joint Research Centre European Commission  Ispra Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kyriakopoulou","sequence":"additional","affiliation":[{"name":"Health Innovations and Ecosystems Unit, Directorate General Research and Innovation European Commission  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4262-3180","authenticated-orcid":false,"given":"Peter","family":"Mol","sequence":"additional","affiliation":[{"name":"Medicines Evaluation Board (MEB)  Utrecht The Netherlands"},{"name":"Department of Clinical Pharmacy and Pharmacology University of Groningen, University Medical Center Groningen  Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Day","sequence":"additional","affiliation":[{"name":"European Medicines Agency  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3974-4237","authenticated-orcid":false,"given":"Kieran","family":"Breen","sequence":"additional","affiliation":[{"name":"Research Centre St Andrew's Healthcare  Northampton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Bennett","sequence":"additional","affiliation":[{"name":"TREAT\u2010NMD Services Ltd  Newcastle\u2010upon\u2010Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mencia","family":"de Lemus Belmonte","sequence":"additional","affiliation":[{"name":"SMA Europe  Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bennett","sequence":"additional","affiliation":[{"name":"Biogen  Maidenhead UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-1699","authenticated-orcid":false,"given":"Patrice","family":"Verpillat","sequence":"additional","affiliation":[{"name":"European Medicines Agency  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit C. B.","family":"Roes","sequence":"additional","affiliation":[{"name":"Department IQ Health, Biostatistics Radboud University Medical Center  Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cochino","sequence":"additional","affiliation":[{"name":"European Medicines Agency  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I Heidelberg University Hospital  Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Mar\u00eda","family":"Hern\u00e1ndez\u2010Rivas","sequence":"additional","affiliation":[{"name":"Department of Medicine, IBSAL University of Salamanca, Hospital Universitario de Salamanca  Salamanca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9757-9754","authenticated-orcid":false,"given":"Patricia","family":"McGettigan","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute Queen Mary University of London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Arlett","sequence":"additional","affiliation":[{"name":"European Medicines Agency  Amsterdam The Netherlands"},{"name":"London School of Hygiene and Tropical Medicines  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"e_1_2_10_1_1","unstructured":"HMA\/EMA Big Data Steering Group (BDSG).Report<https:\/\/www.ema.europa.eu\/en\/documents\/report\/big\u2010data\u2010steering\u2010group\u2010bdsg\u20102024\u2010report_en.pdf> (2024)."},{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3603"},{"key":"e_1_2_10_3_1","unstructured":"Joint HMA\u2010EMA Network Data Steering Group<https:\/\/www.ema.europa.eu\/en\/about\u2010us\/how\u2010we\u2010work\/data\u2010regulation\u2010big\u2010data\u2010other\u2010sources\/network\u2010data\u2010steering\u2010group\u2010ndsg> (2025)."},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2479"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3596"},{"key":"e_1_2_10_6_1","unstructured":"EMA Guideline on registry\u2010based studies<https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/guideline\u2010registry\u2010based\u2010studies_en.pdf\u20100> (2021)."},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00848-9"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.924648"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2929"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.05.030"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174131"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010025\u201001528\u20107"},{"key":"e_1_2_10_13_1","unstructured":"Qualification of novel methodologies for medicine development<https:\/\/www.ema.europa.eu\/en\/qualification\u2010novel\u2010methodologies\u2010medicine\u2010development>."},{"key":"e_1_2_10_14_1","unstructured":"Big data workplan 2023\u20132025<https:\/\/www.ema.europa.eu\/system\/files\/documents\/work\u2010programme\/workplan\u20102023\u20102025\u2010hmaema\u2010joint\u2010big\u2010data\u2010steering\u2010group_en.pdf> (2024)."},{"key":"e_1_2_10_15_1","unstructured":"EMA Initiative for Patient Registries.https:\/\/www.ema.europa.eu\/en\/human\u2010regulatory\u2010overview\/post\u2010authorisation\/patient\u2010registries(2015)."},{"key":"e_1_2_10_16_1","unstructured":"Joint HMA\/EMA multistakeholder workshop on patient Registries<https:\/\/www.ema.europa.eu\/en\/events\/joint\u2010heads\u2010medicines\u2010agencies\u2010hma\u2010european\u2010medicines\u2010agency\u2010ema\u2010multistakeholder\u2010workshop\u2010patient\u2010registries> (February2024)."},{"key":"e_1_2_10_17_1","unstructured":"Report of the joint HMA\/EMA multistakeholder workshop on patient Registries<https:\/\/www.ema.europa.eu\/en\/documents\/report\/report\u2010joint\u2010hma\u2010ema\u2010multi\u2010stakeholder\u2010workshop\u2010patient\u2010registries_en.pdf> (June2024)."},{"key":"e_1_2_10_18_1","unstructured":"EMA multi\u2010stakeholder workshop on qualification of novel methodologies<https:\/\/www.ema.europa.eu\/en\/events\/ema\u2010multi\u2010stakeholder\u2010workshop\u2010qualification\u2010novel\u2010methodologies> (2024)."},{"key":"e_1_2_10_19_1","unstructured":"European Coordination Action for Research in Cystic Fibrosis (EUROCARECF): <https:\/\/cordis.europa.eu\/project\/id\/18932>."},{"key":"e_1_2_10_20_1","unstructured":"Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in Hematology (HARMONY)<https:\/\/cordis.europa.eu\/project\/id\/116026>."},{"key":"e_1_2_10_21_1","unstructured":"Registry\u2010based cohort study of Spinal Muscular Atrophy (SMA) disease to describe the natural history of SMA the evolution of SMA care management and disease progression considering new disease modifying therapies (DMTs)<https:\/\/catalogues.ema.europa.eu\/node\/3582\/administrative\u2010details> (2024)."},{"key":"e_1_2_10_22_1","unstructured":"TREAT\u2010NMD Network<https:\/\/www.treat\u2010nmd.org\/>"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1408636"},{"key":"e_1_2_10_24_1","unstructured":"Data quality framework<https:\/\/data\u2010quality\u2010framework\u2010eu\u2010medicines\u2010regulation_en_1.pdf>(europa.eu) (2023)."},{"key":"e_1_2_10_25_1","unstructured":"Draft Data Quality Framework for EU medicines regulation: application to Real\u2010World Data<https:\/\/www.ema.europa.eu\/en\/about\u2010us\/how\u2010we\u2010work\/big\u2010data\/data\u2010quality\u2010framework\u2010medicines\u2010regulation#assessing\u2010real\u2010world\u2010data\u2010quality\u201071852>."},{"key":"e_1_2_10_26_1","unstructured":"HMA\/EMA Catalogues of real\u2010world data sources and studies<https:\/\/catalogues.ema.europa.eu\/> (2024)."},{"key":"e_1_2_10_27_1","unstructured":"European Network of Centres for Pharmacoepidemiology & Pharmacovigilance (ENCePP) initiative<https:\/\/encepp.europa.eu\/index_en>."},{"key":"e_1_2_10_28_1","unstructured":"European Rare Disease Registry Infrastructure (ERDRI)<https:\/\/eu\u2010rd\u2010platform.jrc.ec.europa.eu\/erdri_en>."},{"key":"e_1_2_10_29_1","unstructured":"European Health Data Space (EHDS)<https:\/\/health.ec.europa.eu\/ehealth\u2010digital\u2010health\u2010and\u2010care\/european\u2010health\u2010data\u2010space_en>"},{"key":"e_1_2_10_30_1","unstructured":"Virtual Platform of the European Joint Programme on Rare Diseases (EJP RD)<https:\/\/vp.ejprarediseases.org\/>."},{"key":"e_1_2_10_31_1","unstructured":"European Medicines Agency<https:\/\/www.ema.europa.eu\/en\/homepage>."},{"key":"e_1_2_10_32_1","unstructured":"Guideline on good pharmacovigilance practices (GVP). Module VIII \u2013 Post\u2010authorisation safety studies (Rev 3).(europa.eu) (2017)."},{"key":"e_1_2_10_33_1","unstructured":"Scientific guidance on post\u2010authorisation efficacy studies<https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/scientific\u2010guidance\u2010post\u2010authorisation\u2010efficacy\u2010studies\u2010first\u2010version_en.pdf> (2017)."},{"key":"e_1_2_10_34_1","unstructured":"EUnetHTA members REQueST tool and its vision paper \u2010 EUnetHTA<https:\/\/www.eunethta.eu\/request\u2010tool\u2010and\u2010its\u2010vision\u2010paper\/> (2019)."},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2466"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2883"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1480"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3021"},{"key":"e_1_2_10_39_1","unstructured":"ICH M14: general principles on plan design and analysis of pharmacoepidemiological studies that utilize Real\u2010World Data for safety assessment of medicines<https:\/\/www.ich.org\/page\/multidisciplinary\u2010guidelines#14\u20101>."},{"key":"e_1_2_10_40_1","unstructured":"Future proofing of qualification of novel methodologies \u2013 Action plan<https:\/\/www.ema.europa.eu\/en\/documents\/other\/future\u2010proofing\u2010qualification\u2010novel\u2010methodologies\u2010qonm\u2010action\u2010plan_en.pdf> (2024)."},{"key":"e_1_2_10_41_1","unstructured":"Opinions and letters of support on the qualification of novel methodologies for medicine development<https:\/\/www.ema.europa.eu\/en\/human\u2010regulatory\u2010overview\/research\u2010development\/scientific\u2010advice\u2010protocol\u2010assistance\/opinions\u2010letters\u2010support\u2010qualification\u2010novel\u2010methodologies\u2010medicine\u2010development>."},{"key":"e_1_2_10_42_1","unstructured":"Qualification opinion on The European Cystic Fibrosis Society Patient Registry (ECFSPR) and CF pharmaco\u2010epidemiology studies<https:\/\/www.ema.europa.eu\/en\/documents\/regulatory\u2010procedural\u2010guideline\/qualification\u2010opinion\u2010european\u2010cystic\u2010fibrosis\u2010society\u2010patient\u2010registry\u2010ecfspr\u2010and\u2010cf\u2010pharmaco\u2010epidemiology\u2010studies_en.pdf> (2018)."},{"key":"e_1_2_10_43_1","unstructured":"Qualification opinion on cellular therapy module of the European Society for Blood & Marrow Transplantation (EBMT) Registry<https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/qualification\u2010opinion\u2010cellular\u2010therapy\u2010module\u2010european\u2010society\u2010blood\u2010marrow\u2010transplantation\u2010ebmt\u2010registry_en.pdf> (2019)."},{"key":"e_1_2_10_44_1","unstructured":"Letter of support for International Niemann\u2010Pick Disease Registry (INPDR)<https:\/\/www.ema.europa.eu\/en\/documents\/other\/letter\u2010support\u2010international\u2010niemann\u2010pick\u2010disease\u2010registry\u2010inpdr_en.pdf> (2021)."},{"key":"e_1_2_10_45_1","unstructured":"Letter of Support for performing registry\u2010based post authorisation safety studies (PASS) in Multiple Sclerosis (MS) using data of the Big MS Data Network (BMSD)<https:\/\/www.ema.europa.eu\/en\/documents\/other\/letter\u2010support\u2010performing\u2010registry\u2010based\u2010post\u2010authorisation\u2010safety\u2010studies\u2010pass\u2010multiple\u2010sclerosis\u2010ms\u2010using\u2010data\u2010big\u2010ms\u2010data\u2010network\u2010bmsd_en.pdf> (2022)."},{"key":"e_1_2_10_46_1","unstructured":"Qualification opinion of the use of Enroll\u2010HD (a Huntington's disease patient registry) as a data source and infrastructure support for post\u2010authorisation monitoring of medical products<https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/qualification\u2010opinion\u2010use\u2010enroll\u2010hd\u2010huntingtons\u2010disease\u2010patient\u2010registry\u2010data\u2010source\u2010and\u2010infrastructure\u2010support\u2010post\u2010authorisation\u2010monitoring\u2010medical\u2010products_en.pdf> (2022)."},{"key":"e_1_2_10_47_1","unstructured":"Letter of support for TREAT\u2010NMD core dataset for spinal muscular atrophy (SMA)<https:\/\/www.ema.europa.eu\/en\/documents\/other\/letter\u2010support\u2010treat\u2010nmd\u2010core\u2010dataset\u2010spinal\u2010muscular\u2010atrophy\u2010sma_en.pdf> (2022)."},{"key":"e_1_2_10_48_1","unstructured":"Letter of Support for World Federation of Hemophilia (WFH) Gene Therapy Registry (GTR)<https:\/\/www.ema.europa.eu\/en\/documents\/leaflet\/letter\u2010support\u2010world\u2010federation\u2010hemophilia\u2010wfh\u2010gene\u2010therapy\u2010registry\u2010gtr_en.pdf> (2023)."},{"key":"e_1_2_10_49_1","unstructured":"EMA Regulatory science strategy to 2025<https:\/\/www.ema.europa.eu\/en\/documents\/regulatory\u2010procedural\u2010guideline\/ema\u2010regulatory\u2010science\u20102025\u2010strategic\u2010reflection_en.pdf> (2020)."}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.3733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T05:58:51Z","timestamp":1755237531000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.3733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1002\/cpt.3733"],"URL":"https:\/\/doi.org\/10.1002\/cpt.3733","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"2024-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}